What is the translation of " RANDOMISED " in Croatian? S

Adjective
Noun
randomiziranom
randomised
randomizirani
randomised
randomiziranih
randomised
randomiziranog
randomised
randomiziran
randomised
randomizirano je
Conjugate verb

Examples of using Randomised in English and their translations into Croatian

{-}
  • Colloquial category close
  • Ecclesiastic category close
  • Computer category close
Randomised phase 3 study vs. docetaxel CA209017.
Randomizirano ispitivanje faze 3 naspram docetaksela CA209017.
A total of 1,106 patients were randomised, 553 to each arm.
Ukupan broj od 1106 bolesnika je randomiziran po 553 ispitanika u svaki krak.
Randomised phase 3 study vs. dacarbazine CA209066.
Randomizirano ispitivanje faze 3 naspram dakarbazina CA209066.
Children with SMEI were included in a randomised, placebo-controlled, add-on trial.
Dijete sa SMEI je bilo uključeno u randomiziranu placebo kontroliranu studiju tipa add-on.
Randomised phase 3 study vs. chemotherapy CA209037.
Randomizirano ispitivanje faze 3 naspram kemoterapije CA209037.
Only one study reported the main outcome of live birth per woman randomised;
Samo je jedna studija izvjestila živorođenost kao glavni ishod po ženi koja je randomizirana;
In the randomised Glivec and the IFN+Ara-C groups, respectively p=0.073, log-rank test.
U randomiziranoj Glivec, odnosno INF+Ara-C skupini p=0, 073, log-rang test.
Table 3 Percentage change in mean andmedian UFC levels per randomised dose group at month 6 and month 12 compared to baseline values.
Tablica 3 Postotak promjene srednjih razina imedijana razina UFC-a po skupinama randomiziranim po dozama u 6. i 12. mjesecu u usporedbi s početnim vrijednostima.
Of the patients randomised to the chemotherapy arm, 48% crossed over and subsequently received treatment with pembrolizumab.
Među bolesnicima randomiziranima za primanje kemoterapije, njih 48% prešlo je u drugu skupinu i nakon toga primalo liječenje pembrolizumabom.
Safety and performance of Biatain Ibu has been documented by the largest randomised, comparative clinical trials ever performed on a wound dressing.
Sigurnost i učinkovitost proizvoda Biatain Ibu dokumentirane su u najvećim, randomiziranim, usporednim kliničkim ispitivanjima koja su ikada izvedene na oblogama za rane.
The 649 randomised patients(641 treated) had Karnofsky Performance Status(KPS) of≥ 70%, no CNS metastases and adequate organ function.
Randomizirano je 649 bolesnika(od kojih je 641 liječen) općeg statusa po Karnofskom ≥ 70%, bez metastaza u središnjem živčanom sustavu i sa zadovoljavajućom funkcijom organa.
Among patients who remained on the Simponi treatment to which they were randomised at study start, DAS28 and HAQ DI responses were maintained through week 104.
U bolesnika koji su nastavili uzimati Simponi koji im je randomizacijom bio dodijeljen na početku ispitivanja odgovori DAS28 i HAQ DI održali su se do 104. tjedna.
Of the 2,532 randomised intention-to-treat(ITT) patients, a total of 59 patients experienced at least one new vertebral fracture, placebo: 42(3.37)- Preotact: 17(1.32), p0.001.
Od 2532 randomizirane bolesnice s namjerom liječenja(ITT), njih ukupno 59 imalo je najmanje jedan novi prijelom kralješka, placebo: 42(3,3%)- Preotact: 17(1,32%), p=0, 001.
The incidence of elevations in serum creatinine following treatment with Edarbi was similar to placebo in the randomised placebo-controlled monotherapy studies.
U randomiziranim, placebom kontroliranim ispitivanjima monoterapije, incidencija povišenja kreatinina u serumu nakon liječenja Edarbijem bila je slična onoj uz placebo.
Fifty-seven patients randomised to ofatumumab crossed over following progression to receive IMBRUVICA.
Pedeset i sedam bolesnika randomiziranih da primaju ofatumumab, nakon progresije prešlo je na lijek IMBRUVICA.
Female patients with breast cancer andradiologically confirmed bone metastases were randomised to receive placebo(158 patients) or 6 mg ibandronic acid 154 patients.
Bolesnice s rakom dojke iradiološki potvrđenim koštanim metastazama randomizirane su za primanje placeba(158 bolesnica) ili 6 mg ibandronatne kiseline 154 bolesnica.
A total of 3,602 patients were randomised to receive either bivalirudin(1,800 patients) or unfractionated heparin plus a GP IIb/IIIa inhibitor 1,802 patients.
Randomizirano je ukupno 3602 bolesnika koji su primali ili bivalirudin(1800 bolesnika), ili nefrakcionirani heparin s inhibitorom GP IIb/IIIa 1802 bolesnika.
The clinical efficacy of Esbriet has been studied in four Phase 3, multicentre, randomised, double-blind, placebo-controlled studies in patients with IPF.
Klinička djelotvornost lijeka Esbriet ispitivana je u četirima multicentričnim, randomiziranim, dvostruko slijepim, placebom kontroliranim ispitivanjima faze 3 u bolesnika s IPF-om.
A randomised, double-blind, parallel-group non-inferiority study compared the relative efficacy of two different daily maintenance doses of leflunomide, 10 mg and 20 mg.
Randomiziranim, dvostruko slijepim, neinferiornim ispitivanjem paralelnih skupina uspoređivala se relativna djelotvornost dviju različitih dnevnih doza održavanja leflunomida, odnosno 10 i 20 mg.
Four mood stabilizer subgroups were assessed in the randomised phase: aripiprazole+ lithium; aripiprazole+ valproate; placebo+ lithium; placebo+ valproate.
Četiri podskupine stabilizatora raspoloženja su se procjenjivale u randomiziranoj fazi: aripiprazol+ litij, aripiprazol+ valproat, placebo+ litij, placebo+ valproat.
In randomised, controlled, double-blind clinical trials(including developmental and postmarketing experience), over 17,000 patients with type 2 diabetes have been treated with Onglyza.
U randomiziranim, kontroliranim, dvostruko slijepim kliničkim ispitivanjima(uključujući iskustvo tijekom razvoja lijeka i nakon njegova stavljanja u promet) lijekom Onglyza je liječeno više od 17 000 bolesnika sa šećernom bolešću tipa 2.
Figure 5: Kaplan-Meier estimate of overall survival by randomised treatment arm for disease stage IIIB/IIIC/ stage IVM1a exploratory subgroup analysis.
Slika 5: Kaplan-Meierova procjena sveukupnog preživljenja po randomiziranoj terapijskoj skupini za stadij bolesti IIIB/IIIC/stadij bolesti IVM1a eksploratorna analiza podskupina.
The safety and efficacy of Humira were also studied in adult patients with moderate to severe chronic plaque psoriasis with concomitant hand and/or foot psoriasis who were candidates for systemic therapy in a randomised double-blind study Psoriasis Study III.
Sigurnost i djelotvornost lijeka Humira također se ispitivala u odraslih bolesnika s umjerenom do teškom kroničnom plak psorijazom i istodobnom psorijazom šaka i/ili stopala koji su bili kandidati za sistemsku terapiju u randomiziranom, dvostruko slijepom ispitivanju Psoriasis Study III.
The final efficacy analysis included all randomised patients(197 CHOP, 202 R-CHOP), and had a median follow-up duration of approximately 31 months.
Završna analiza djelotvornosti obuhvatila je sve randomizirane bolesnike(197 CHOP, 202 R-CHOP), a medijan praćenja iznosio je približno 31 mjesec.
During the 6-month randomised phase of study GS-US-205-0110, treatment-emergent isolation of MSSA and MRSA was observed more commonly among aztreonam-treated patients than Tobramycin Nebuliser Solution(TNS)-treated patients.
Tijekom 6-mjesečne randomizirane faze ispitivanja GS-US-205-0110, izolacija MSSA-e i MRSA-e prouzročenih liječenjem, primijećena je više kod bolesnika liječenih aztreonamom nego s otopinom tobramicina za atomizator TNS-om, Tobramycin Nebuliser Solution.
The efficacy of Fortacin was demonstrated in two multi-centre,multinational, randomised, double-blind, placebo controlled studies, both followed by an open-label phase.
Djelotvornost lijeka Fortacin dokazana je u dvije multicentrične,multinacionalne, randomizirane, dvostruko slijepe, placebom kontrolirane studije, obje naknadno praćene otvorenom fazom.
There are no prospectively randomised comparisons of the two recommended mobilisation methods(filgrastim alone, or in combination with myelosuppressive chemotherapy) within the same patient population.
Nema prospektivnih, randomiziranih usporedbi dvije preporučene metode mobilizacije(samo filgrastimom ili u kombinaciji s mijelosupresivnom kemoterapijom) u iste populacije bolesnika.
Among patients who remained on the Simponi treatment to which they were randomised at study start, improvement of the SF-36 physical component was maintained through week 104.
Kod bolesnika koji su nastavili liječenje lijekom Simponi koje im je randomizacijom bilo dodijeljeno na početku ispitivanja, poboljšanje SF-36 fizičke komponente održalo se do 104. tjedna.
Study G2305 was a randomised, double-blind, placebo-controlled,4-week study assessing the short- term efficacy of Ilaris in 84 patients randomised to receive a single dose of 4 mg/kg(up to 300 mg) Ilaris or placebo.
Ispitivanje G2305 bilo je randomizirano, dvostruko slijepo,placebom kontrolirano, 4-tjedno ispitivanje kojim se ocjenjivala kratkoročna djelotvornost Ilarisa u 84 bolesnika randomiziranih na primanje jednokratne doze od 4 mg/kg(do 300 mg) Ilarisa ili placeba.
The degree of CD54 upregulation correlates with overall survival in the randomised controlled clinical trials carried out with Provenge in metastatic castrate resistant prostate cancer.
Stupanj povećanja izraženosti CD54 antigena korelira s ukupnim preživljenjem u randomiziranim kontroliranim kliničkim ispitivanjima lijeka Provenge provedenim za metastatski rak prostate rezistentan na kastraciju.
Results: 965, Time: 0.0417
S

Synonyms for Randomised

randomize

Top dictionary queries

English - Croatian